Page URL: https://www.bionews.org.uk/page_2519

CRISPR/Cas9

A genome-editing platform that uses an enzyme (Cas9) to make a double-stranded break at a specific location in the genome, directed by a guide RNA.

Articles using this Glossary Item

Page 1 of 10
First genome editing treatment for HIV enters clinical trials 27 September 2021 News
Over one million potential genome-editing enzymes discovered in microbes 20 September 2021 News
More positive results from CRISPR trial for sickle cell and thalassaemia 16 August 2021 News
Changing the Human Genome: What Next for Germline Genome Editing? 19 July 2021 Comment
CRISPR genome editing blocks SARS-CoV-2 replication 19 July 2021 News
Should we edit human embryos' genomes, and if so then how? 12 July 2021 Comment
CRISPR genome editing treatment shows promise for genetic disorder 5 July 2021 News
Human organoid gives insight into neural tube development 28 June 2021 News
Book Review: The Code Breaker – Jennifer Douda, gene editing and the future of the human race 14 June 2021 Review
Book Review: CRISPR People – The science and ethics of editing humans 1 June 2021 Review
Machine learning technique detects epigenetic drivers of cancers 17 May 2021 News
Potential genetic target for leukaemia treatment identified 10 May 2021 News
Retron genome editing approach is faster and easier than CRISPR 10 May 2021 News
CRISPR genome editing corrects a Duchenne muscular dystrophy deletion mutation in mice 4 May 2021 News
New algorithm developed to improve personalised cancer therapy 4 May 2021 News
Podcast Review: A Brief History of CRISPR – How we learned to edit the genome 4 May 2021 Review
New CRISPR-based gene therapy for single-gene conditions 26 April 2021 News
New genetic drug target for treatment resistant colorectal cancer 19 April 2021 News
Novel CRISPR approach uses an on-off switch for epigenome editing 19 April 2021 News
Researchers warn of unintended effects from CRISPR genome editing 19 April 2021 News
Page 1 of 10

Events using this Glossary Item

Page 1 of 0